Nabil MANSOURI is an experienced medical representative with a focus on promoting innovative therapies in healthcare. Currently serving at Concentrix as a medical visitor since March 2025, Nabil is responsible for developing action plans based on national and regional objectives and optimizing sector performance. Prior experience includes a role at FuturMed from June 2022 to June 2024, where Nabil promoted therapies to healthcare specialists while ensuring adherence to regulatory and legislative requirements. At Hikma Pharmaceuticals, from January 2019 to May 2022, Nabil launched innovative biotherapies for cancer and autoimmune diseases and developed strategies for key accounts. Nabil's career began at Merck KgaA, where from October 2008 to September 2018, responsibilities included scientific information dissemination in oncology to over 200 healthcare professionals. Nabil holds a degree in veterinary medicine from Université Hadj Lakhdar de Batna and is pursuing further education in medical representation.
This person is not in the org chart
This person is not in any teams
This person is not in any offices